Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1

Published:2023 Issue:6 Volume:37 Page:431
ISSN:1674-8301
Container-title:The Journal of Biomedical Research
language:
Short-container-title:J Biomed Res

Author:

Xu Minqin,Zhang Lihua,Lin Lan,Qiang Zhiyi,Liu Wei,Yang Jian

Publisher

Journal of Biomedical Research

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference34 articles.

1. Ghosh S. Cisplatin: the first metal based anticancer drug[J]. Bioorg Chem, 2019, 88: 102925.

2. Tesniere A, Schlemmer F, Boige V, et al. Immunogenic death of colon cancer cells treated with oxaliplatin[J]. Oncogene, 2010, 29(4): 482–491.

3. Muttar A, Ahmed I, Hameed H. The optimum inhibitory effects of Alpha Interferon and Cisplatin in colon cancer, a comparative in vitro study[J]. J Med Life, 2022, 15(2): 269–277.

4. Kim SJ, Park C, Lee JN, et al. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins[J]. Toxicol Appl Pharmacol, 2015, 288(2): 192–202.

5. Pezeshki Z, Khosravi A, Nekuei M, et al. Time course of cisplatin-induced nephrotoxicity and hepatotoxicity[J]. J Nephropathol, 2017, 6(3): 163–167.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review;Expert Opinion on Drug Metabolism & Toxicology;2024-05-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3